Showing results (1-10 of 197) with videos related to
Sort By:
Pageof 20
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Clinical points for progressive muscular dystrophy - is immobobilization the only concern?]Hirofumi KomakiBrain & Development|July 25, 2025
Duchenne muscular dystrophy: Evolving therapeutic strategies and multidimensional evaluation approachesHirofumi KomakiNo to Hattatsu = Brain and Development|September 11, 2015
[Update of steroid therapy for Duchenne muscular dystrophy]Fumi Takeuchi, Hirofumi KomakiRinsho Shinkeigaku = Clinical Neurology|October 29, 2019
[Study of medical management for patients with Duchenne muscular dystrophy in Japan: what was changed by a practical guideline]Tsuyoshi Matsumura, Hirofumi KomakiRinsho Shinkeigaku = Clinical Neurology|July 10, 2015
[Survey of the actual state of medical care of patients with Duchenne muscular dystrophy in Japan]Tsuyoshi Matsumura, Hirofumi Komaki, Mitsuru KawaiNeuromuscular Disorders : NMD|January 11, 2025
Holter electrocardiography findings in Fukuyama congenital muscular dystrophyRyo Sugiyama, Eri Takeshita, Yuko Shimizu-Motohashi, et al.No to Hattatsu = Brain and Development|November 11, 2006
[Two boys with non-progressive unilateral atrophy of the calf muscles]Masayuki Sasaki, Tsuyoshi Oomi, Masami Segawa, et al.Pediatric Neurology|January 8, 2013
Congenital hypomyelinating neuropathy attributable to a de novo p.Asp61Asn mutation of the myelin protein zero geneTakahiro Yonekawa, Hirofumi Komaki, Yuko Saito, et al.Journal of the Neurological Sciences|July 19, 2022
Determining neurodevelopmental manifestations in Duchenne muscular dystrophy using a battery of brief testsYoshihiko Saito, Eri Takeshita, Hirofumi Komaki, et al.STAR Protocols|June 8, 2025
Protocol for using MYOD1-transduced human urine-derived cells as a predictive platform for exon skipping therapy in Duchenne muscular dystrophyKatsuhiko Kunitake, Takami Ishizuka, Eri Takeshita, et al.Pageof 20